Shai Izraeli
Researcher Next ID · RN-042291
Researcher · Biochemistry, Genetics and Molecular Biology
Tel Aviv, Israel
- Works count
- 413
- Citation count
- 14,640
- H-index
- 61
- i10-index
- 176
Research interests
Publications
The KMT2A recombinome of acute leukemias in 2023
Leukemia · 2023 · 10.1038/s41375-023-01877-1
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Blood Advances · 2020 · 10.1182/bloodadvances.2019000901
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Blood Advances · 2020 · 10.1182/bloodadvances.2019000901
IKZF1 plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Journal of Clinical Oncology · 2018 · 10.1200/jco.2017.74.3617
The MLL recombinome of acute leukemias in 2017
Leukemia · 2017 · https://doi.org/10.1038/leu.2017.213
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Cancer Cell · 2016 · 10.1016/j.ccell.2016.03.008
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.59.1636
The MLL recombinome of acute leukemias in 2013
Leukemia · 2013 · https://doi.org/10.1038/leu.2013.135
The landscape of somatic mutations in Down syndrome–related myeloid disorders
Nature Genetics · 2013 · 10.1038/ng.2759
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
Blood · 2013 · 10.1182/blood-2013-06-509463
Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002
Journal of Clinical Oncology · 2013 · 10.1200/jco.2013.48.6522
MiR-125 in normal and malignant hematopoiesis
Leukemia · 2012 · 10.1038/leu.2012.90
Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
Cell · 2012 · 10.1016/j.cell.2012.06.032
Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
Cell · 2012 · 10.1016/j.cell.2012.06.032
STIL is required for centriole duplication in human cells
Journal of Cell Science · 2012 · 10.1242/jcs.104109
Gain-of-function mutations in interleukin-7 receptor-α ( IL7R ) in childhood acute lymphoblastic leukemias
The Journal of Experimental Medicine · 2011 · 10.1084/jem.20110580
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
Blood · 2010 · 10.1182/blood-2009-11-256131
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
Blood · 2009 · 10.1182/blood-2008-11-163501
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
Blood · 2009 · https://doi.org/10.1182/blood-2009-08-235408
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.19.4134
New insights to the MLL recombinome of acute leukemias
Leukemia · 2009 · https://doi.org/10.1038/leu.2009.33
The Expression of Three Genes in Primary Non–Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain
Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-2124
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)61341-0
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
Blood · 2007 · 10.1182/blood-2007-09-114231
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
Blood · 2007 · 10.1182/blood-2007-09-114231
The SIL gene is required for mouse embryonic axial development and left–right specification
Nature · 1999 · 10.1038/21429
The SIL gene is required for mouse embryonic axial development and left–right specification
Nature · 1999 · 10.1038/21429
Current projects
No projects listed.